New Key Statistics Module, Z-Score and F-Score
NYSE:DNA Key Ratios
| Market Cap $ M | 1,859.02 |
| Enterprise Value $ M | 1,076.62 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.53 |
| Price/Sales | 6.49 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 208.00 |
| EPS (TTM) $ | -0.44 |
| Beneish M-Score | -4.42 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.21 |
| EV-to-EBITDA | -1.31 |
| PEG | -- |
| Shares Outstanding M | 2,211.28 |
| Net Margin (%) | -355.08 |
| Operating Margin % | -305.50 |
| Pre-tax Margin (%) | -355.11 |
| Quick Ratio | 6.11 |
| Current Ratio | 6.11 |
| ROA % (ttm) | -40.81 |
| ROE % (ttm) | -62.03 |
| ROIC % (ttm) | -74.22 |
| Dividend Yield % | -- |
| Altman Z-Score | -3.69 |
DNA Number of Guru Trades
DNA Volume of Guru Trades
Gurus Latest Trades with NYSE:DNA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:DNA is held by these investors
Total 2
Ginkgo Bioworks Holdings Inc Insider Transactions
No Available Data
News about NYSE:DNA
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers